J. KNIPPER & COMPANY, — Febuxostat Importer Profile
Pharmaceutical Importer · #4 buyer for Febuxostat · $1.1M import value · 31 shipments · UNITED STATES · DGFT Verified
J. KNIPPER & COMPANY, is the #4 importer of Febuxostat from India with $1.1M in import value and 31 verified shipments. J. KNIPPER & COMPANY, holds a 2.2% market share in Febuxostat imports based in UNITED STATES. The company sources from 1 verified supplier across 7 formulations shipped to 1 country. Overall, J. KNIPPER & COMPANY, imports 28 pharmaceutical products worth $68.5M across 14 therapeutic categories.
J. KNIPPER & COMPANY, — Febuxostat Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Febuxostat to J. KNIPPER & COMPANY,?
Verified from 31 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LIMITED | $1.1M | 31 | 100.0% |
J. KNIPPER & COMPANY, sources Febuxostat from 1 verified Indian supplier based on 31 customs records. The primary supplier is ALEMBIC PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does J. KNIPPER & COMPANY, Compare to Nearest Febuxostat Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | UNILAB INC | PHILIPPINES | $1.9M | 39 | $50.0K |
| 2 | AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $1.3M | 25 | $50.0K |
| 4 | J. KNIPPER & COMPANY, ★ | UNITED STATES | $1.1M | 22 | $50.0K |
| 3 | MULTICARE PHARMACEUTICALS | PHILIPPINES | $1.0M | 20 | $50.0K |
| 5 | J KNIPPER COMPANY ★ | UNITED STATES | $1.0M | 20 | $50.0K |
J. KNIPPER & COMPANY, ranks #4 among 421 Febuxostat importers from India. Average shipment value of $50.0K compared to the market average of $26.8K. The closest competitors by value are UNILAB INC and AJANTA PHARMA PHILIPPINES INC.
Where Does J. KNIPPER & COMPANY, Import Febuxostat To?
Destination countries from 31 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 31 | 100.0% |
J. KNIPPER & COMPANY, imports Febuxostat to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.1M.
What Febuxostat Formulations Does J. KNIPPER & COMPANY, Import?
| Formulation | Value | Shipments |
|---|---|---|
| FEBUXOSTAT TABLETS 40MG 30 S AP US | $527.2K | 12 |
| FEBUXOSTAT TABLETS 80MG 30 S AP US | $276.8K | 8 |
| FEBUXOSTAT TABLETS 40MG 30'S AP US | $165.1K | 4 |
| FEBUXOSTAT TABLETS 80MG 30'S AP US | $86.0K | 3 |
| FEBUXOSTAT TABLETS 40MG 30S AP US (16128X30S TABS) | $50.0K | 1 |
| FEBUXOSTAT TABLETS 80MG 30S AP US | $26.4K | 2 |
| FEBUXOSTAT TABLETS 40MG 30 ' S AP US | $14.7K | 1 |
J. KNIPPER & COMPANY, imports 7 distinct Febuxostat formulations from India. The top formulation is FEBUXOSTAT TABLETS 40MG 30 S AP US with 12 shipments worth $527.2K.
Regulatory Requirements: Importing Febuxostat into United States
What J. KNIPPER & COMPANY, and other importers must comply with to import Febuxostat from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Febuxostat
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Febuxostat from India and How Much Does J. KNIPPER & COMPANY, Import?
India exported $11.3M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. J. KNIPPER & COMPANY, imports $1.1M of this total, accounting for 2.2% of India's Febuxostat exports with 31 shipments from UNITED STATES. This is verified from 31 customs shipment records covering 7 distinct formulations.
What Is the Average Order Value for J. KNIPPER & COMPANY,'s Febuxostat Imports?
J. KNIPPER & COMPANY,'s average Febuxostat order value is $37.0K per consignment, based on 31 shipments totaling $1.1M. J. KNIPPER & COMPANY, is based in UNITED STATES and ranks #4 among all Febuxostat importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Febuxostat to J. KNIPPER & COMPANY,?
J. KNIPPER & COMPANY, sources Febuxostat from 1 verified Indian supplier: ALEMBIC PHARMACEUTICALS LIMITED ($1.1M, 100.0%). This is based on 31 customs records.
How Does J. KNIPPER & COMPANY, Compare to Other Febuxostat Importers?
J. KNIPPER & COMPANY, ranks #4 among 421 Febuxostat importers from India with a 2.2% market share. The top 3 importers are UNILAB INC ($1.9M), AJANTA PHARMA PHILIPPINES INC ($1.3M), J. KNIPPER & COMPANY, ($1.1M). J. KNIPPER & COMPANY, processed 31 shipments from UNITED STATES.
About J. KNIPPER & COMPANY,
J. KNIPPER & COMPANY, imports 28 products worth $68.5M. Beyond Febuxostat, top products include Celecoxib, Losartan, Valsartan, Doxycycline, Azithromycin. View the complete J. KNIPPER & COMPANY, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: J. KNIPPER & COMPANY, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as J. KNIPPER & COMPANY,'s capped import value divided by total capped export value for Febuxostat across all Indian exporters.
- 5.Verified Records: This page is backed by 31 individual customs records matching J. KNIPPER & COMPANY, importing Febuxostat, covering 7 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Import Data for J. KNIPPER & COMPANY,
Access order-level details, pricing data, supplier connections, and competitive analysis for J. KNIPPER & COMPANY,'s Febuxostat imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
J. KNIPPER & COMPANY,
Full Company Profile →
28 products · $68.5M total trade · 14 categories
J. KNIPPER & COMPANY, × Febuxostat
Verified from customs records
Company Overview
Top Products by J. KNIPPER & COMPANY,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for J. KNIPPER & COMPANY,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current order-level data, contact TransData Nexus.